Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies

@inproceedings{Gerich2013PathogenesisAM,
  title={Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies},
  author={John E. Gerich},
  booktitle={International journal of general medicine},
  year={2013}
}
Postprandial plasma glucose concentrations are an important contributor to glycemic control. There is evidence suggesting that postprandial hyperglycemia may be an independent risk factor for cardiovascular disease. Glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors are antidiabetic agents that predominantly reduce postprandial plasma glucose levels. DPP-4 inhibitors are associated with fewer gastrointestinal side effects than GLP-1 receptor agonists… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 144 references

Similar Papers

Loading similar papers…